Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,053,775
  • Shares Outstanding, K 91,157
  • Annual Sales, $ 0 K
  • Annual Income, $ -245,600 K
  • EBIT $ -274 M
  • EBITDA $ -267 M
  • 60-Month Beta 1.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.13

Options Overview Details

View History
  • Implied Volatility 87.73% ( -1.49%)
  • Historical Volatility 52.44%
  • IV Percentile 83%
  • IV Rank 49.00%
  • IV High 131.39% on 10/02/24
  • IV Low 45.78% on 07/23/24
  • Put/Call Vol Ratio 0.38
  • Today's Volume 469
  • Volume Avg (30-Day) 272
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 8,755
  • Open Int (30-Day) 7,241

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.72
  • Number of Estimates 8
  • High Estimate -0.62
  • Low Estimate -0.79
  • Prior Year -0.64
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.15 +3.68%
on 12/20/24
15.01 -22.98%
on 11/25/24
-1.48 (-11.35%)
since 11/20/24
3-Month
11.15 +3.68%
on 12/20/24
20.31 -43.08%
on 09/23/24
-8.61 (-42.69%)
since 09/20/24
52-Week
11.15 +3.68%
on 12/20/24
32.53 -64.46%
on 12/28/23
-16.34 (-58.57%)
since 12/20/23

Most Recent Stories

More News
3 Small-Cap Stocks That Are Ready to Rocket Higher

With lower interest rates and lower corporate taxes more likely, it's a good time to consider three small-cap stocks that present a buying opportunity

FVRR : 32.28 (+0.88%)
GM : 51.81 (+2.92%)
RCKT : 11.56 (+1.85%)
LAC : 2.97 (+1.02%)
Rocket Pharma Stock Slips Despite New Long-Term Data On Phase-I Study; Retail Sentiment Slides

Danon disease is a rare genetic disorder whose complications can ultimately cause heart failure, and for male patients, frequent death.

VXF : 192.94 (+1.36%)
VTI : 293.28 (+1.14%)
RCKT : 11.56 (+1.85%)
IWM : 221.92 (+0.94%)
Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline in Focus

Rocket Pharmaceuticals, Inc. RCKT incurred a loss of 71 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 78 cents. In the year-ago quarter, the company...

FOLD : 9.80 (+0.72%)
IMCR : 28.33 (-0.33%)
CSTL : 27.53 (+1.62%)
RCKT : 11.56 (+1.85%)
Rocket Pharmaceuticals: Q3 Earnings Snapshot

Rocket Pharmaceuticals: Q3 Earnings Snapshot

RCKT : 11.56 (+1.85%)
Rocket Pharmaceuticals: Q2 Earnings Snapshot

Rocket Pharmaceuticals: Q2 Earnings Snapshot

RCKT : 11.56 (+1.85%)
Stocks Slide on the Last Trading Day of Q2

The S&P 500 Index ($SPX ) (SPY ) today is down -0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. Stock indexes today are lower...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
SYF : 65.45 (+1.84%)
MRVL : 111.90 (+2.56%)
AMD : 119.21 (+0.28%)
NXPI : 210.24 (+1.43%)
KLAC : 629.37 (+1.16%)
Stocks Climb as the Fed’s Favored Inflation Gauge Falls

The S&P 500 Index ($SPX ) (SPY ) today is up +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.35%. Stock indexes today are moderately...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
URI : 722.64 (+1.65%)
HUM : 247.10 (+4.80%)
UNH : 500.13 (+2.22%)
SYF : 65.45 (+1.84%)
TSLA : 421.06 (-3.46%)
Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals

Rocket could launch its medicines sooner, but Intellia is aiming for larger markets.

NTLA : 12.18 (+0.83%)
RCKT : 11.56 (+1.85%)
Rocket Pharmaceuticals Stock Is Blasting Off, but Here's Why You Should Tread Carefully

Its near-term risks are subtle but bigger than their flying stock price might indicate.

RCKT : 11.56 (+1.85%)
Betting on Rocket Pharmaceuticals (RCKT)? Check the Options Flow Data First.

Although Rocket Pharmaceuticals lived up to its name on Wednesday due to an encouraging clinical trial development, the big dogs have some questions about RCKT stock.

RCKT : 11.56 (+1.85%)
RCKT|20231020|17.50C : N/A (N/A)
RCKT|20240119|25.00C : N/A (N/A)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States....

See More

Key Turning Points

3rd Resistance Point 12.49
2nd Resistance Point 12.14
1st Resistance Point 11.85
Last Price 11.56
1st Support Level 11.21
2nd Support Level 10.86
3rd Support Level 10.57

See More

52-Week High 32.53
Fibonacci 61.8% 24.36
Fibonacci 50% 21.84
Fibonacci 38.2% 19.32
Last Price 11.56
52-Week Low 11.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar